[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Atypical Antipsychotic Drugs Information

 Aripiprazole (marketed as Abilify); Clozapine (marketed as Clozaril); Olanzapine (marketed as Zyprexa); Olanzapine/Fluoxetine (marketed as Symbyax); Quetiapine (marketed as Seroquel); 
Risperidone (marketed as Risperdal); Ziprasidone (marketed as Geodon); 

 

Patient Information Sheets (updated September 6, 2006)

  • Aripiprazole (marketed as Abilify)  [PDF] [HTML]

  • Clozapine (marketed as Clozaril)  [PDF] [HTML]

  • Olanzapine (marketed as Zyprexa)  [PDF] [HTML]

  • Olanzapine/Fluoxetine (marketed as Symbyax) [PDF] [HTML]

  • Risperidone (marketed as Risperdal)  [PDF] [HTML]

  • Quetiapine (marketed as Seroquel)  [PDF] [HTML]

  • Ziprasidone (marketed as Geodon)  [PDF] [HTML]

Healthcare Professional Information: Approval History and Labeling from Drugs@FDA

Historical Information

Back to Top     Back to Drug Index

PDF requires the free Adobe Acrobat Reader

Date created: April 11, 2005, updated September 6, 2006

horizonal rule